Literature DB >> 34894367

Tailoring Hyperbranched Poly(β-amino ester) as a Robust and Universal Platform for Cytosolic Protein Delivery.

Xun Liu1,2, Ziyin Zhao2, Fan Wu2, Yongbing Chen1, Lichen Yin2.   

Abstract

Cytosolic protein delivery is a prerequisite for protein-based biotechnologies and therapeutics on intracellular targets. Polymers that can complex with proteins to form nano-assemblies represent one of the most important categories of materials, because of the ease of nano-fabrication, high protein loading efficiency, no need for purification, and maintenance of protein bioactivity. Stable protein encapsulation and efficient intracellular liberation are two critical yet opposite processes toward cytosolic delivery, and polymers that can resolve these two conflicting challenges are still lacking. Herein, hyperbranched poly(β-amino ester) (HPAE) with backbone-embedded phenylboronic acid (PBA) is developed to synchronize these two processes, wherein PBA enhanced protein encapsulation via nitrogen-boronate (N-B) coordination while triggered polymer degradation and protein release upon oxidation by H2 O2 in cancer cells. Upon optimization of the branching degree, charge density, and PBA distribution, the best-performing A2-B3-C2-S2 -P2 is identified, which mediates robust delivery of various native proteins/peptides with distinct molecular weights (1.6-430 kDa) and isoelectric points (4.1-10.3) into cancer cells, including enzymes, toxins, antibodies, and CRISPR-Cas9 ribonucleoproteins (RNPs). Moreover, A2-B3-C2-S2 -P2 mediates effective cytosolic delivery of saporin both in vitro and in vivo to provoke remarkable anti-tumor efficacy. Such a potent and universal platform holds transformative potentials for protein pharmaceuticals.
© 2022 Wiley-VCH GmbH.

Entities:  

Keywords:  N-B coordination; ROS-degradability; branched polymers; charge density; cytosolic protein delivery; gene editing

Mesh:

Substances:

Year:  2022        PMID: 34894367     DOI: 10.1002/adma.202108116

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  1 in total

1.  Cardiomyocyte-targeted anti-inflammatory nanotherapeutics against myocardial ischemia reperfusion (IR) injury.

Authors:  Min Lan; Mengying Hou; Jing Yan; Qiurong Deng; Ziyin Zhao; Shixian Lv; Juanjuan Dang; Mengyuan Yin; Yong Ji; Lichen Yin
Journal:  Nano Res       Date:  2022-07-27       Impact factor: 10.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.